Literature DB >> 25782162

Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.

Yanchun Wang1, Zhongguang Luo, Yongfu Pan, Weige Wang, Xiaoyan Zhou, Lak Shin Jeong, Yiwei Chu, Jie Liu, Lijun Jia.   

Abstract

Recent studies indicate that post-translational protein neddylation is required for the maintenance of cell viability in several lymphoma cell lines, while inhibition of the neddylation pathway with an NEDD8-activating enzyme (NAE) inhibitor MLN4924 induces apoptosis in lymphoma cells. However, the mechanism by which neddylation inhibition induces apoptosis in lymphoma cells has not been fully elucidated. Moreover, it is unknown whether neddylation inhibition triggers non-apoptotic cell-killing responses, such as cell senescence, in lymphoma cells. Here, we report that MLN4924 specifically inhibited protein neddylation, inactivated cullin-RING E3 ligase (CRL), the best-known neddylation substrate, and induced the accumulation of tumor-suppressive CRL substrates in lymphoma cells. Moreover, MLN4924 potently suppressed the growth of lymphoma cells by inducing G2 cell-cycle arrest, followed by apoptosis or senescence in a cell line-dependent manner. MLN4924-induced apoptosis was mediated by intrinsic apoptotic signaling with substantial up-regulation of pro-apoptotic Bik and Noxa as well as down-regulation of anti-apoptotic XIAP, c-IAP1 and c-IAP2, while senescence induction upon neddylation inhibition seemed dependent on the expression of tumor suppressor p21/p27. Together, these findings expand our understanding on how lymphoma cells respond to neddylation inhibition and support the development of neddylation inhibitors (e.g. MLN4924) for the treatment of lymphoma.

Entities:  

Keywords:  CRL, cullin-RING E3 ligase; GCB-DLBCL, germinal-center B cell-like diffuse large B-cell lymphoma; IAP, inhibitor of apoptosis; MLN4924; NAE, NEDD8-activating enzyme; NHL, non-Hodgkin lymphoma; SA-β-gal, senescence-associated β-galactosidase; apoptosis; lymphoma; neddylation; senescence

Mesh:

Substances:

Year:  2015        PMID: 25782162      PMCID: PMC4623239          DOI: 10.1080/15384047.2014.1003003

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  61 in total

1.  Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.

Authors:  Hui-Kuan Lin; Zhenbang Chen; Guocan Wang; Caterina Nardella; Szu-Wei Lee; Chia-Hsin Chan; Chan-Hsin Chan; Wei-Lei Yang; Jing Wang; Ainara Egia; Keiichi I Nakayama; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

Review 2.  Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Gwénaël Rabut; Matthias Peter
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

3.  Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.

Authors:  Michael A Milhollen; Usha Narayanan; Teresa A Soucy; Petter O Veiby; Peter G Smith; Benjamin Amidon
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

4.  Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines.

Authors:  Bhaswati Sarcar; Soumen Kahali; Antony H Prabhu; Stuart D Shumway; Yang Xu; Tim Demuth; Prakash Chinnaiyan
Journal:  Mol Cancer Ther       Date:  2011-10-12       Impact factor: 6.261

5.  DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation.

Authors:  Regina Miftakhova; Tove Sandberg; Andreas Hedblom; Tatyana Nevzorova; Jenny L Persson; Anders Bredberg
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

Review 6.  Novel substrates and functions for the ubiquitin-like molecule NEDD8.

Authors:  Dimitris P Xirodimas
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

7.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

Review 8.  MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.

Authors:  Steffan T Nawrocki; Patrick Griffin; Kevin R Kelly; Jennifer S Carew
Journal:  Expert Opin Investig Drugs       Date:  2012-07-16       Impact factor: 6.206

9.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

10.  Targeting the neddylation pathway to suppress the growth of prostate cancer cells: therapeutic implication for the men's cancer.

Authors:  Xiaofang Wang; Lihui Li; Yupei Liang; Chunjie Li; Hu Zhao; Dingwei Ye; Menghong Sun; Lak Shin Jeong; Yan Feng; Shen Fu; Lijun Jia; Xiaomao Guo
Journal:  Biomed Res Int       Date:  2014-06-29       Impact factor: 3.411

View more
  16 in total

1.  Neddylation inhibitor MLN4924 induces G2 cell cycle arrest, DNA damage and sensitizes esophageal squamous cell carcinoma cells to cisplatin.

Authors:  Shan Lin; Zhaoyang Shang; Shuo Li; Peng Gao; Yi Zhang; Shuaiheng Hou; Peng Qin; Ziming Dong; Tao Hu; Ping Chen
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

2.  Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.

Authors:  Gonzalo N Olaverria Salavaggione; Megan C Duggan; William E Carson
Journal:  Melanoma Res       Date:  2018-10       Impact factor: 3.599

Review 3.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

4.  The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription.

Authors:  Shan Liu; Haiyan Liu; Ru Qin; Yi Shu; Zhidai Liu; Penghui Zhang; Caiwen Duan; Dengli Hong; Jie Yu; Lin Zou
Journal:  Cell Death Dis       Date:  2017-04-20       Impact factor: 8.469

5.  The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth via triggering autophagy.

Authors:  Yongzhu Lv; Bing Li; Kunna Han; Yang Xiao; Xianjun Yu; Yong Ma; Zhan Jiao; Jianjun Gao
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

6.  Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.

Authors:  Zelong Yang; Jie Zhang; Xiaotong Lin; Di Wu; Guixi Li; Chunlian Zhong; Lei Fang; Peng Jiang; Liangyu Yin; Leida Zhang; Ping Bie; Chuan-Ming Xie
Journal:  Oncol Rep       Date:  2019-04-04       Impact factor: 3.906

7.  Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells.

Authors:  Xiaofang Wang; Wenjuan Zhang; Zi Yan; Yupei Liang; Lihui Li; Xiaoli Yu; Yan Feng; Shen Fu; Yanmei Zhang; Hu Zhao; Jinha Yu; Lak Shin Jeong; Xiaomao Guo; Lijun Jia
Journal:  Oncotarget       Date:  2016-06-21

8.  MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.

Authors:  Yi Zhang; Cheng-Cheng Shi; Hua-Peng Zhang; Gong-Quan Li; Shan-Shan Li
Journal:  Oncotarget       Date:  2016-07-19

9.  Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.

Authors:  Ping Xie; Jun-Ping Yang; Yun Cao; Li-Xia Peng; Li-Sheng Zheng; Rui Sun; Dong-Fang Meng; Meng-Yao Wang; Yan Mei; Yuan-Yuan Qiang; Li Cao; Yan-Qun Xiang; Dong-Hua Luo; Jing-Ping Yun; Bi-Jun Huang; Li-Jun Jia; Chao-Nan Qian
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

10.  Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection.

Authors:  Xiao-Lu Ma; Xing-Hui Gao; Zi-Jun Gong; Jiong Wu; Lu Tian; Chun-Yan Zhang; Yan Zhou; Yun-Fan Sun; Bo Hu; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Wei Guo; Xin-Rong Yang
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.